Gamco Investors INC. ET AL Has $24.31 Million Position in Henry Schein, Inc. $HSIC

Key Points

• Gamco Investors INC. ET AL increased its holdings in Henry Schein, Inc. by 2.0%, now owning 354,970 shares valued at approximately $24.3 million, as reported in its recent SEC filing.
• Henry Schein's latest earnings report showed an EPS of $1.10, missing the consensus estimate and reflecting a year-over-year revenue growth of 3.3% to $3.24 billion.
• Current analyst ratings for Henry Schein are mixed, with five analysts giving a Buy rating and seven a Hold rating, while the consensus target price is set at $76.67.

Gamco Investors INC. ET AL increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 2.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 354,970 shares of the company's stock after purchasing an additional 6,892 shares during the period. Gamco Investors INC. ET AL owned approximately 0.29% of Henry Schein worth $24,312,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in HSIC. FORA Capital LLC bought a new stake in shares of Henry Schein during the 1st quarter valued at $785,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Henry Schein by 1,357.1% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 4,182 shares of the company's stock valued at $286,000 after acquiring an additional 3,895 shares during the period. AlphaQuest LLC bought a new stake in shares of Henry Schein during the 1st quarter valued at $1,068,000. Allstate Corp lifted its position in shares of Henry Schein by 9.8% during the 1st quarter. Allstate Corp now owns 4,416 shares of the company's stock valued at $302,000 after acquiring an additional 394 shares during the period. Finally, Norinchukin Bank The lifted its position in shares of Henry Schein by 14.9% during the 1st quarter. Norinchukin Bank The now owns 6,761 shares of the company's stock valued at $463,000 after acquiring an additional 879 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Price Performance

Shares of Henry Schein stock traded up $0.55 during trading on Friday, reaching $69.58. 1,021,767 shares of the company's stock were exchanged, compared to its average volume of 2,115,911. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a market cap of $8.44 billion, a P/E ratio of 22.45, a PEG ratio of 2.30 and a beta of 0.81. The firm's 50-day moving average price is $70.35 and its 200 day moving average price is $70.04.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period in the previous year, the company earned $1.23 EPS. Henry Schein's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Wall Street Zen upgraded Henry Schein from a "hold" rating to a "buy" rating in a research report on Saturday. Barrington Research cut their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 target price for the company in a research report on Tuesday, August 26th. Robert W. Baird reiterated a "neutral" rating and set a $72.00 target price (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Finally, Wells Fargo & Company lowered their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.